Search for Clinical Trial Results
Herpes Genitalis - 25 Studies Found
Status | Study |
Completed |
Study Name: A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes Condition: Herpes Genitalis Date: 2007-06-12 Interventions:
|
Completed |
Study Name: A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies. Condition: Herpes Genitalis Date: 2005-09-08 Interventions: Drug: valaciclovir (VALTREX®) |
Completed |
Study Name: Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients Condition: Genital Herpes Date: 2007-05-22 Interventions:
|
Completed |
Study Name: Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes Condition: Recurrent Genital Herpes Date: 2005-09-13 Interventions: Drug: Famciclovir |
Completed |
Study Name: Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes Condition: Genital Herpes Date: 2006-03-22 Interventions:
|
Active, not recruiting |
Study Name: Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine Condition: Herpes Genitalis Date: 2016-07-13 Interventions:
|
Completed |
Study Name: Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding Condition:
Date: 2005-09-09 Interventions: Drug: Valacyclovir |
Terminated |
Study Name: Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes Condition: Genital Herpes Date: 2012-08-03 Interventions:
|
Completed |
Study Name: Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes Condition: GENITAL HERPES Date: 2011-01-20 Interventions:
|
Terminated |
Study Name: A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes Condition: Genital Herpes Date: 2012-12-14 Interventions: Drug: PEG-Formulation |